Vor Biopharma signs exclusive license pact with NCI for clinical-stage CD33 CAR-T EP News Bureau Nov 11, 2020 It is currently being evaluated in a multi-site Phase 1/2 clinical trial in children and young adults with relapsed or refractory…
